Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Virtual Conference 2021 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#1457 Small and Large Incidental Non-Hyperfunctiong Pancreatic Neuroendocrine Tumors: Spectrum of Magnetic Resonance Imaging Features

Introduction: The improvement of imaging techniques significantly increased the detection of small incidental non-hyperfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs). Most NF-PanNENs <2 cm are likely benign lesions and a non-operative approach could be advocated in selected cases for these lesions.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: De Robertis R, D'Onofrio M, Butturini G, Tinazzi Martini P, Paiella S,

Keywords: Pancreas, neuroendocrine neoplasms, magnetic resonance imaging,

#1226 Follow Up of ≤ 2 cm Non Functioning Pancreatic NETs in Patients with MEN1 Treated with Conservative Approach

Introduction: There is a current trend for conservative treatment of non functioning pancreatic NET (NF-PNETs), ≤ 2 cm, in patients with MEN1, which are reported to be associated with low risk of metastasis and death.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Davi' M

Authors: Davì M, Cosaro E, Malpaga A, Butturini G, Ortolani S,

Keywords: Pancreatic neuroendocrine tumor, MEN1,

#1198 Role of Combined 68Ga-DOTATOC and 18F-FDG PET-CT in the Diagnostic Workup of Well Differentiated Pancreas Neuroendocrine Tumors (PanNETs): A Surgical Series

Introduction: PanNETs have a broad spectrum of aggressiveness. Somatostatin-receptor based functional imaging, [68Ga]DOTATOC-PET/CT (GP), is recommended in the diagnostic workup of PanNETs; preliminary evidences show that [18F]FDG-PET/CT (FP) can provide prognostic information.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Ortolani S, Butturini G, Malpaga A, Cingarlini S, Malfatti V,

Keywords: pancreas neuroendocrine tumor, PET, tumor grade,

#858 Metastatic Pancreatic Neuroendocrine Tumors with Ectopic Cushing Syndrome: Could Everolimus Be a Safe Therapeutic Option?

Introduction: Everolimus(E) has proved effective in prolonging PFS in advanced P-NETs. As E is a substrate of CYP3A4 co-administration with ketoconazole (k), a strong inhibitor of CYP3A4 used to control hypercortisolism, should be avoided.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: davi' m

Authors: Davì M, Cingarlini S, Butturini G, Capelli P, Scarpa A,

Keywords: Everolimus, pancreatic NET, ectopic Cushing syndrome,

Abstract Submissions in 2022

Abstract submissions for 2022 will open in September 2021!

 

The 19th Annual ENETS Conference in 2022 will provide the principal platform for NET researchers around the world to present their latest findings. ENETS will select the best abstracts submitted in both clinical and basic science and present these in sessions within the framework of its scientific programme.

 

Participants of the ENETS Virtual Conference 2021 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.